RenaissanceRe Holdings Ltd. (NYSE:RNR - Free Report) - Research analysts at Zacks Research dropped their Q2 2025 earnings estimates for shares of RenaissanceRe in a research report issued on Tuesday, May 6th. Zacks Research analyst K. Dey now anticipates that the insurance provider will post earnings of $10.76 per share for the quarter, down from their previous estimate of $11.40. The consensus estimate for RenaissanceRe's current full-year earnings is $26.04 per share. Zacks Research also issued estimates for RenaissanceRe's FY2025 earnings at $21.60 EPS, Q1 2026 earnings at $7.01 EPS, Q3 2026 earnings at $6.89 EPS, FY2026 earnings at $36.15 EPS and FY2027 earnings at $41.12 EPS.
RenaissanceRe (NYSE:RNR - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The insurance provider reported ($1.49) EPS for the quarter, missing the consensus estimate of ($0.32) by ($1.17). RenaissanceRe had a return on equity of 23.41% and a net margin of 15.99%. The firm had revenue of $3.44 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter last year, the company posted $12.18 EPS. RenaissanceRe's revenue for the quarter was up 7.6% on a year-over-year basis.
Other research analysts have also issued research reports about the stock. Keefe, Bruyette & Woods raised their price objective on shares of RenaissanceRe from $279.00 to $282.00 and gave the company an "outperform" rating in a research note on Tuesday, April 29th. Barclays lowered their price target on RenaissanceRe from $234.00 to $231.00 and set an "underweight" rating on the stock in a research report on Friday, April 11th. Jefferies Financial Group cut their price objective on RenaissanceRe from $266.00 to $265.00 and set a "hold" rating for the company in a report on Friday, April 11th. Morgan Stanley raised RenaissanceRe from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $235.00 to $275.00 in a research note on Friday, April 25th. Finally, Wells Fargo & Company dropped their price target on shares of RenaissanceRe from $277.00 to $271.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, RenaissanceRe has an average rating of "Hold" and a consensus target price of $282.60.
Check Out Our Latest Analysis on RenaissanceRe
RenaissanceRe Stock Performance
Shares of NYSE RNR traded down $2.56 during midday trading on Friday, reaching $240.88. 151,263 shares of the company traded hands, compared to its average volume of 426,028. RenaissanceRe has a 52 week low of $208.98 and a 52 week high of $300.00. The company has a market cap of $11.72 billion, a price-to-earnings ratio of 6.88, a PEG ratio of 2.09 and a beta of 0.34. The stock has a 50-day moving average price of $239.96 and a 200 day moving average price of $249.54. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.42 and a quick ratio of 1.42.
RenaissanceRe Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Friday, June 13th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.60 dividend on an annualized basis and a yield of 0.66%. RenaissanceRe's dividend payout ratio is presently 5.10%.
Insider Buying and Selling at RenaissanceRe
In related news, CAO James Christopher Fraser sold 332 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were sold at an average price of $249.54, for a total value of $82,847.28. Following the sale, the chief accounting officer now directly owns 27,154 shares of the company's stock, valued at approximately $6,776,009.16. The trade was a 1.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.00% of the company's stock.
Hedge Funds Weigh In On RenaissanceRe
A number of large investors have recently modified their holdings of RNR. Summit Financial LLC bought a new stake in RenaissanceRe during the first quarter worth $3,131,000. Price T Rowe Associates Inc. MD raised its stake in RenaissanceRe by 37.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,496,035 shares of the insurance provider's stock valued at $599,049,000 after buying an additional 676,125 shares during the period. Credit Agricole S A lifted its position in shares of RenaissanceRe by 74.9% in the first quarter. Credit Agricole S A now owns 11,270 shares of the insurance provider's stock valued at $2,705,000 after buying an additional 4,826 shares during the last quarter. Van Lanschot Kempen Investment Management N.V. boosted its stake in shares of RenaissanceRe by 12.3% during the 1st quarter. Van Lanschot Kempen Investment Management N.V. now owns 245,977 shares of the insurance provider's stock worth $59,034,000 after acquiring an additional 27,028 shares during the period. Finally, Quantbot Technologies LP acquired a new position in shares of RenaissanceRe during the 1st quarter worth approximately $4,553,000. 99.97% of the stock is currently owned by institutional investors and hedge funds.
About RenaissanceRe
(
Get Free Report)
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S.
Read More

Before you consider RenaissanceRe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RenaissanceRe wasn't on the list.
While RenaissanceRe currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report